- Home
- ILAG vs ADXN Comparison
ILAG vs ADXN Comparison
Compare ILAG & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILAG | ADXN |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | Hong Kong | Switzerland |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 10.3M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ILAG | ADXN |
|---|---|---|
| Price | $4.16 | $7.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 25.2K | 6.7K |
| Earning Date | 12-22-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,338,785.00 | $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.74 | $6.51 |
| 52 Week High | $9.80 | $12.05 |
Technical Indicators
Market Signals| Indicator | ILAG | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 88.60 | 46.21 |
| Support Level | $0.30 | $7.66 |
| Resistance Level | $5.26 | $8.90 |
| Average True Range (ATR) | 0.18 | 0.43 |
| MACD | 0.39 | 0.02 |
| Stochastic Oscillator | 77.94 | 38.62 |
Price Performance
Historical ComparisonAbout ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.